Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Schermuly

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
The European Respiratory Journal|November 23, 2007
Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibitionE Dony, Y-J Lai, R Dumitrascu, et al.
Pneumologie (Stuttgart, Germany)|March 10, 2015
[Riociguat: stimulator of soluble guanylate-cyclase. New mode of action for the treatment of pulmonary arterial and non operable chronic thromboembolic pulmonary hypertension]H H Leuchte, J Behr, R Ewert, et al.
Oncogene|April 25, 2012
Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIFS S Pullamsetti, G A Banat, A Schmall, et al.
British Journal of Pharmacology|May 1, 2014
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertensionS Crnkovic, B Egemnazarov, P Jain, et al.
The European Respiratory Journal|November 18, 2008
Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxiaK Woyda, S Koebrich, I Reiss, et al.
The European Respiratory Journal|October 16, 2010
Terguride ameliorates monocrotaline-induced pulmonary hypertension in ratsR Dumitrascu, C Kulcke, M Königshoff, et al.
The European Respiratory Journal|June 10, 2010
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertensionB K Dahal, D Kosanovic, P K Pamarthi, et al.
British Journal of Pharmacology|March 18, 2011
A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysmM Revermann, A Mieth, L Popescu, et al.
The European Respiratory Journal|June 14, 2008
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertensionR T Schermuly, J-P Stasch, S S Pullamsetti, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Pathobiology, pathology and genetics of pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016]A Olschewski, E M Berghausen, C A Eichstaedt, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
The European Respiratory Journal|November 23, 2007
Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibitionE Dony, Y-J Lai, R Dumitrascu, et al.
Pneumologie (Stuttgart, Germany)|March 10, 2015
[Riociguat: stimulator of soluble guanylate-cyclase. New mode of action for the treatment of pulmonary arterial and non operable chronic thromboembolic pulmonary hypertension]H H Leuchte, J Behr, R Ewert, et al.
Oncogene|April 25, 2012
Phosphodiesterase-4 promotes proliferation and angiogenesis of lung cancer by crosstalk with HIFS S Pullamsetti, G A Banat, A Schmall, et al.
British Journal of Pharmacology|May 1, 2014
NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertensionS Crnkovic, B Egemnazarov, P Jain, et al.
The European Respiratory Journal|November 18, 2008
Inhibition of phosphodiesterase 4 enhances lung alveolarisation in neonatal mice exposed to hyperoxiaK Woyda, S Koebrich, I Reiss, et al.
The European Respiratory Journal|October 16, 2010
Terguride ameliorates monocrotaline-induced pulmonary hypertension in ratsR Dumitrascu, C Kulcke, M Königshoff, et al.
The European Respiratory Journal|June 10, 2010
Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertensionB K Dahal, D Kosanovic, P K Pamarthi, et al.
British Journal of Pharmacology|March 18, 2011
A pirinixic acid derivative (LP105) inhibits murine 5-lipoxygenase activity and attenuates vascular remodelling in a murine model of aortic aneurysmM Revermann, A Mieth, L Popescu, et al.
The European Respiratory Journal|June 14, 2008
Expression and function of soluble guanylate cyclase in pulmonary arterial hypertensionR T Schermuly, J-P Stasch, S S Pullamsetti, et al.
Deutsche Medizinische Wochenschrift (1946)|October 21, 2016
[Pathobiology, pathology and genetics of pulmonary hypertension: Recommendations of the Cologne Consensus Conference 2016]A Olschewski, E M Berghausen, C A Eichstaedt, et al.
Pageof 4